Cargando…

Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center

BACKGROUND: Management of renal cell carcinoma (RCC) with tumor thrombus extending to the renal vein and inferior vena cava (IVC) is challenging. The aim of this study was to evaluate the benefit of surgical management in such patients. METHODS: From February 1995 to February 2013, 520 patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatakeyama, Shingo, Yoneyama, Takahiro, Hamano, Itsuto, Murasawa, Hiromi, Narita, Takuma, Oikawa, Masaaki, Hagiwara, Kazuhisa, Noro, Daisuke, Tanaka, Toshikazu, Tanaka, Yoshimi, Hashimoto, Yasuhiro, Koie, Takuya, Ohyama, Chikara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852853/
https://www.ncbi.nlm.nih.gov/pubmed/24125174
http://dx.doi.org/10.1186/1471-2490-13-47
_version_ 1782478740174929920
author Hatakeyama, Shingo
Yoneyama, Takahiro
Hamano, Itsuto
Murasawa, Hiromi
Narita, Takuma
Oikawa, Masaaki
Hagiwara, Kazuhisa
Noro, Daisuke
Tanaka, Toshikazu
Tanaka, Yoshimi
Hashimoto, Yasuhiro
Koie, Takuya
Ohyama, Chikara
author_facet Hatakeyama, Shingo
Yoneyama, Takahiro
Hamano, Itsuto
Murasawa, Hiromi
Narita, Takuma
Oikawa, Masaaki
Hagiwara, Kazuhisa
Noro, Daisuke
Tanaka, Toshikazu
Tanaka, Yoshimi
Hashimoto, Yasuhiro
Koie, Takuya
Ohyama, Chikara
author_sort Hatakeyama, Shingo
collection PubMed
description BACKGROUND: Management of renal cell carcinoma (RCC) with tumor thrombus extending to the renal vein and inferior vena cava (IVC) is challenging. The aim of this study was to evaluate the benefit of surgical management in such patients. METHODS: From February 1995 to February 2013, 520 patients were treated for RCC at Hirosaki University Hospital, Hirosaki, Japan. The RCC patients with tumor thrombus extending to the renal vein (n = 42) and IVC (n = 43) were included in this study. The records of these 85 patients were retrospectively reviewed to assess the relevant clinical and pathological variables and survival. Prognostic factors were identified by multivariate analysis. The benefit of surgical management was evaluated using propensity score matching to compare overall survival between patients who received surgical management and those who did not. RESULTS: RCC was confirmed by pathological examination of surgical or biopsy specimens in 74 of the 85 patients (87%). Sixty-five patients (76%) received surgical management (radical nephrectomy with thrombectomy). Distant metastasis was identified in 45 patients (53%). The proportion of patients with tumor thrombus level 0 (renal vein only), I, II, III, and IV was 49%, 13%, 18%, 14%, and 5%, respectively. The estimated 5-year overall survival rate was 70% in patients with thrombus extending to the renal vein and 23% in patients with thrombus extending to the IVC. Multivariate analysis identified thrombus extending to the IVC, presence of distant metastasis, surgical management, serum albumin concentration, serum choline esterase concentration, neutrophil-lymphocyte ratio, and Carlson comorbidity index as independent prognostic factors. In propensity score-matched patients, overall survival was significantly longer in those who received surgical management than those who did not. CONCLUSIONS: Surgical management may improve the prognosis of RCC patients with thrombus extending to the renal vein and IVC.
format Online
Article
Text
id pubmed-3852853
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38528532013-12-07 Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center Hatakeyama, Shingo Yoneyama, Takahiro Hamano, Itsuto Murasawa, Hiromi Narita, Takuma Oikawa, Masaaki Hagiwara, Kazuhisa Noro, Daisuke Tanaka, Toshikazu Tanaka, Yoshimi Hashimoto, Yasuhiro Koie, Takuya Ohyama, Chikara BMC Urol Research Article BACKGROUND: Management of renal cell carcinoma (RCC) with tumor thrombus extending to the renal vein and inferior vena cava (IVC) is challenging. The aim of this study was to evaluate the benefit of surgical management in such patients. METHODS: From February 1995 to February 2013, 520 patients were treated for RCC at Hirosaki University Hospital, Hirosaki, Japan. The RCC patients with tumor thrombus extending to the renal vein (n = 42) and IVC (n = 43) were included in this study. The records of these 85 patients were retrospectively reviewed to assess the relevant clinical and pathological variables and survival. Prognostic factors were identified by multivariate analysis. The benefit of surgical management was evaluated using propensity score matching to compare overall survival between patients who received surgical management and those who did not. RESULTS: RCC was confirmed by pathological examination of surgical or biopsy specimens in 74 of the 85 patients (87%). Sixty-five patients (76%) received surgical management (radical nephrectomy with thrombectomy). Distant metastasis was identified in 45 patients (53%). The proportion of patients with tumor thrombus level 0 (renal vein only), I, II, III, and IV was 49%, 13%, 18%, 14%, and 5%, respectively. The estimated 5-year overall survival rate was 70% in patients with thrombus extending to the renal vein and 23% in patients with thrombus extending to the IVC. Multivariate analysis identified thrombus extending to the IVC, presence of distant metastasis, surgical management, serum albumin concentration, serum choline esterase concentration, neutrophil-lymphocyte ratio, and Carlson comorbidity index as independent prognostic factors. In propensity score-matched patients, overall survival was significantly longer in those who received surgical management than those who did not. CONCLUSIONS: Surgical management may improve the prognosis of RCC patients with thrombus extending to the renal vein and IVC. BioMed Central 2013-10-14 /pmc/articles/PMC3852853/ /pubmed/24125174 http://dx.doi.org/10.1186/1471-2490-13-47 Text en Copyright © 2013 Hatakeyama et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hatakeyama, Shingo
Yoneyama, Takahiro
Hamano, Itsuto
Murasawa, Hiromi
Narita, Takuma
Oikawa, Masaaki
Hagiwara, Kazuhisa
Noro, Daisuke
Tanaka, Toshikazu
Tanaka, Yoshimi
Hashimoto, Yasuhiro
Koie, Takuya
Ohyama, Chikara
Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center
title Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center
title_full Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center
title_fullStr Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center
title_full_unstemmed Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center
title_short Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center
title_sort prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852853/
https://www.ncbi.nlm.nih.gov/pubmed/24125174
http://dx.doi.org/10.1186/1471-2490-13-47
work_keys_str_mv AT hatakeyamashingo prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter
AT yoneyamatakahiro prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter
AT hamanoitsuto prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter
AT murasawahiromi prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter
AT naritatakuma prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter
AT oikawamasaaki prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter
AT hagiwarakazuhisa prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter
AT norodaisuke prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter
AT tanakatoshikazu prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter
AT tanakayoshimi prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter
AT hashimotoyasuhiro prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter
AT koietakuya prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter
AT ohyamachikara prognosticbenefitofsurgicalmanagementinrenalcellcarcinomapatientswiththrombusextendingtotherenalveinandinferiorvenacava17yearexperienceatasinglecenter